Resources
Latest resources
Webinars
The Devil Is In The Details – A Checklist For Developing Successful Eu Pharma And Medtech Forecasts
Forecasting the value of biopharmaceutical and MedTech assets often begins with the US market, given its size and significance
White Papers
Payers and the Inflation Reduction Act
A view into how twelve large national and regional payers are preparing for the IRA, and what their planning means for the future of pharmaceutical forecasting
White Papers
Optimizing Early-Stage Commercial Assessments for Emerging Biopharma
A guide to sizing commercial assessments at each stage of asset development, from early exploration through detailed decision modeling
Engage with Us
Whether your seeking a career or to work with us on a project, we’re excited to chat!
